\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ patient\\ was\\ referred\\ to\\ gynecology\\ by\\ primary\\ care\\ clinician\\.\ \(0\)\
\-\ sonographic\\ images\\ demonstrates\\ a\\ focal\\ hypoechoic\\ area\\ in\\ the\\ junctional\\ zone\\ posteriorly\\ and\\ at\\ the\\ level\\ of\\ the\\ fundus\\.\\ \\ also\\ present\\ were\\ well\\ circumscribed\\ intramural\\ hypoechoic\\ areas\\ compatible\\ with\\ fibroids\\ \\(not\\ shown\\)\\.\ \(0\)\
\-\ mr\\:\ \(0\)\
\-\ axial\\ and\\ sagittal\\ t2\\ weighted\\ sequences\\ of\\ the\\ pelvis\\ demonstrate\\ a\\ focal\\ area\\ of\\ thickening\\ of\\ the\\ junctional\\ zone\\ posteriorly\\ compatible\\ with\\ focal\\ adenomyosis\\.\ \(0\)\
\-\ adenomyosis\ \(10\)\
\-\ adenomyosis\ \(10\)\
\-\ leiomyoma\ \(85\)\
\-\ 35\\ year\\ old\\ with\\ heavy\\ menses\\ and\\ clotting\\.\ \(1\)\
\-\ adenomyosis\\ consists\\ of\\ endometrial\\ glands\\ and\\ stroma\\ within\\ the\\ myometrium\\ with\\ associated\\ myometrial\\ hypertrophy\\.\\ \\ clinically\\,\\ patients\\ present\\ with\\ excessive\\ uterine\\ bleeding\\ with\\ worsening\\ dysmenorrhea\\.\\ \\ these\\ symptoms\\ are\\ nonspecific\\ and\\ are\\ also\\ a\\ sequelae\\ of\\ leiomyoma\\,\\ endometriosis\\ and\\ endometrial\\ polyps\\.\\ \\ adenomyosis\\ occurs\\ in\\ premenopausal\\ women\\.\\ \\ adenomyosis\\ may\\ be\\ diffuse\\ or\\ focal\\.\\ \ \(0\)\
\-\ sonographic\\ findings\\ include\\ uterine\\ enlargement\\ not\\ explained\\ by\\ the\\ presence\\ of\\ leiomyomas\\,\\ asymmetric\\ thickening\\ of\\ the\\ myometrial\\ wall\\,\\ poorly\\ circumscribed\\ areas\\ in\\ the\\ myometrium\\,\\ cysts\\ of\\ varying\\ sizes\\ and\\ increased\\ echogenicity\\ of\\ the\\ myometrium\\.\\ \\ however\\,\\ features\\ are\\ subjective\\.\ \(0\)\
\-\ adenomyosis\\ on\\ t1\\ weighted\\ sequences\\ may\\ not\\ be\\ apparent\\.\\ \\ t2\\ weighted\\ images\\ exhibit\\ low\\ signal\\ intensity\\ in\\ the\\ junctional\\ zone\\ which\\ exceeds\\ a\\ short\\ axis\\ measurement\\ of\\ 11mm\\ in\\ adenomyosis\\.\\ \\ small\\ foci\\ of\\ increased\\ t1\\ and\\ t2\\ signal\\ may\\ represent\\ associated\\ hemorrhage\\ in\\ these\\ lesions\\.\ \(0\)\
\-\ this\\ patient\\ demonstrated\\ a\\ focal\\ area\\ of\\ decreased\\ echogenicity\\ confirmed\\ on\\ mr\\ cmpatible\\ with\\ focal\\ adenomyosis\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ olson\\,\\ m\\,\\ posniak\\,\\ h\\,\\ tempany\\,\\ c\\,\\ and\\ dudiak\\,\\ c\\.\\ \\ \\"mr\\ imaging\\ of\\ the\\ female\\ pelvic\\ region\\.\\"\\ \\ radiographics\\ 1992\\;\\ 12\\:\\ 445\\-465\\.\ \(0\)\
\-\ reinhold\\,\\ c\\,\\ tafazoli\\,\\ f\\,\\ mehio\\,\\ a\\,\\ wang\\,\\ l\\,\\ atri\\,\\ m\\,\\ siegelman\\,\\ e\\,\\ and\\ rohoman\\,\\ l\\.\\ \\ \\"uterine\\ adenomyosis\\:\\ endovaginal\\ us\\ and\\ mr\\ imaging\\ features\\ with\\ histopatholigic\\ correlation\\"\\.\\ \\ radiographics\\ 1999\\;\\ 19\\:\\ s147\\-s160\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adenomyosis\\:\\ 0\\.1898705074310097\ \(0\)\
\-\ myometrium\\:\\ 0\\.059787664635680436\ \(0\)\
\-\ junctional\\:\\ 0\\.0587422530766001\ \(0\)\
\-\ myometrial\\:\\ 0\\.045662166481055554\ \(0\)\
\-\ focal\\:\\ 0\\.04332237167109589\ \(0\)\
\-\ zone\\:\\ 0\\.040285671345713994\ \(0\)\
\-\ uterine\\:\\ 0\\.03891747004547205\ \(0\)\
\-\ c\\:\\ 0\\.036052617451421305\ \(0\)\
\-\ weighted\\:\\ 0\\.032979159729073663\ \(0\)\
\-\ mr\\:\\ 0\\.0321325381295436\ \(0\)\
\-\ leiomyoma\\:\\ 0\\.029771176272474775\ \(0\)\
\-\ radiographics\\:\\ 0\\.029638200794060227\ \(0\)\
\-\ endometrial\\:\\ 0\\.02866997935156436\ \(0\)\
\-\ compatible\\:\\ 0\\.02793594001032188\ \(0\)\
\-\ echogenicity\\:\\ 0\\.027195329696984565\ \(0\)\
\-\ m\\:\\ 0\\.026087569092912693\ \(0\)\
\-\ cmpatible\\:\\ 0\\.026081415455522183\ \(0\)\
\-\ olson\\:\\ 0\\.026081415455522183\ \(0\)\
\-\ posniak\\:\\ 0\\.026081415455522183\ \(0\)\
\-\ tempany\\:\\ 0\\.026081415455522183\ \(0\)\
\-\ dudiak\\:\\ 0\\.026081415455522183\ \(0\)\
\-\ 445\\-465\\.\\:\\ 0\\.026081415455522183\ \(0\)\
\-\ reinhold\\:\\ 0\\.026081415455522183\ \(0\)\
\-\ tafazoli\\:\\ 0\\.026081415455522183\ \(0\)\
\-\ mehio\\:\\ 0\\.026081415455522183\ \(0\)\
\-\ atri\\:\\ 0\\.026081415455522183\ \(0\)\
\-\ rohoman\\:\\ 0\\.026081415455522183\ \(0\)\
\-\ histopatholigic\\:\\ 0\\.026081415455522183\ \(0\)\
\-\ s147\\-s160\\:\\ 0\\.026081415455522183\ \(0\)\
\-\ sonographic\\:\\ 0\\.02451295615091474\ \(0\)\
\-\ premenopausal\\:\\ 0\\.024030684152090392\ \(0\)\
\-\ siegelman\\:\\ 0\\.024030684152090392\ \(0\)\
\-\ area\\:\\ 0\\.023980795066280477\ \(0\)\
\-\ posteriorly\\:\\ 0\\.023883993673698038\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.023050517740463745\ \(0\)\
\-\ l\\:\\ 0\\.023050517740463745\ \(0\)\
\-\ circumscribed\\:\\ 0\\.022474784539358424\ \(0\)\
\-\ dysmenorrhea\\:\\ 0\\.021979952848658602\ \(0\)\
\-\ 11mm\\:\\ 0\\.021979952848658602\ \(0\)\
\-\ t2\\:\\ 0\\.02146676421967768\ \(0\)\
\-\ features\\:\\ 0\\.0213374690599117\ \(0\)\
\-\ sequences\\:\\ 0\\.021115351194118413\ \(0\)\
\-\ \\,\\:\\ 0\\.020823851193637492\ \(0\)\
\-\ leiomyomas\\:\\ 0\\.019929221545226812\ \(0\)\
\-\ exceeds\\:\\ 0\\.019929221545226812\ \(0\)\
\-\ wang\\:\\ 0\\.019929221545226812\ \(0\)\
\-\ gynecology\\:\\ 0\\.019269033523587137\ \(0\)\
\-\ endovaginal\\:\\ 0\\.019269033523587137\ \(0\)\
\-\ clotting\\:\\ 0\\.01849280788906793\ \(0\)\
\-\ 1992\\:\\ 0\\.017530019722101577\ \(0\)\
\-\ endometriosis\\:\\ 0\\.017370057528994256\ \(0\)\
\-\ thickening\\:\\ 0\\.017139790353215098\ \(0\)\
\-\ menses\\:\\ 0\\.01707395262202093\ \(0\)\
\-\ stroma\\:\\ 0\\.01707395262202093\ \(0\)\
\-\ explained\\:\\ 0\\.01707395262202093\ \(0\)\
\-\ areas\\:\\ 0\\.017013888587254833\ \(0\)\
\-\ exhibit\\:\\ 0\\.016804805349222924\ \(0\)\
\-\ \\:\\:\\ 0\\.016720041656666643\ \(0\)\
\-\ subjective\\:\\ 0\\.016678889330232403\ \(0\)\
\-\ may\\:\\ 0\\.01663605061152181\ \(0\)\
\-\ heavy\\:\\ 0\\.01655811419851567\ \(0\)\
\-\ sizes\\:\\ 0\\.01655811419851567\ \(0\)\
\-\ measurement\\:\\ 0\\.01655811419851567\ \(0\)\
\-\ clinician\\:\\ 0\\.016222822230151757\ \(0\)\
\-\ fibroids\\:\\ 0\\.016222822230151757\ \(0\)\
\-\ intramural\\:\\ 0\\.016119001757337346\ \(0\)\
\-\ t1\\:\\ 0\\.016026600806060613\ \(0\)\
\-\ excessive\\:\\ 0\\.015319326225562464\ \(0\)\
\-\ polyps\\:\\ 0\\.015319326225562464\ \(0\)\
\-\ glands\\:\\ 0\\.01502322131858914\ \(0\)\
\-\ sequelae\\:\\ 0\\.01502322131858914\ \(0\)\
\-\ e\\:\\ 0\\.01502322131858914\ \(0\)\
\-\ varying\\:\\ 0\\.014819100397030114\ \(0\)\
\-\ fundus\\:\\ 0\\.014628158026800614\ \(0\)\
\-\ 1999\\:\\ 0\\.01433498967578218\ \(0\)\
\-\ correlation\\:\\ 0\\.013919066744950257\ \(0\)\
\-\ consists\\:\\ 0\\.013870958695033747\ \(0\)\
\-\ axis\\:\\ 0\\.013469936529364446\ \(0\)\
\-\ signal\\:\\ 0\\.013331800770844844\ \(0\)\
\-\ h\\:\\ 0\\.013307781983521267\ \(0\)\
\-\ f\\:\\ 0\\.013191744370641736\ \(0\)\
\-\ these\\:\\ 0\\.01315884433111148\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.01300792253304704\ \(0\)\
\-\ nonspecific\\:\\ 0\\.01300792253304704\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.0124268345422001\ \(0\)\
\-\ increased\\:\\ 0\\.012369732436684353\ \(0\)\
\-\ poorly\\:\\ 0\\.012340613978772562\ \(0\)\
\-\ women\\:\\ 0\\.012284258372350388\ \(0\)\
\-\ asymmetric\\:\\ 0\\.012284258372350388\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.012187866875634574\ \(0\)\
\-\ \\;\\:\\ 0\\.011984740760074518\ \(0\)\
\-\ associated\\:\\ 0\\.011931731135548532\ \(0\)\
\-\ short\\:\\ 0\\.011917238701729149\ \(0\)\
\-\ imaging\\:\\ 0\\.011846590677252087\ \(0\)\
\-\ 19\\:\\ 0\\.01165775473599215\ \(0\)\
\-\ 35\\:\\ 0\\.01163525592124298\ \(0\)\
\-\ present\\:\\ 0\\.011420170141607578\ \(0\)\
\-\ apparent\\:\\ 0\\.011179188821162334\ \(0\)\
\-\ represent\\:\\ 0\\.011103323641832932\ \(0\)\
\-\ clinically\\:\\ 0\\.011084657460787772\ \(0\)\
\-\ bleeding\\:\\ 0\\.010975067899603307\ \(0\)\
\-\ not\\:\\ 0\\.010959929039129604\ \(0\)\
\-\ foci\\:\\ 0\\.010852141855482382\ \(0\)\
\-\ us\\:\\ 0\\.01060476274293465\ \(0\)\
\-\ references\\:\\ 0\\.010511326139235541\ \(0\)\
\-\ occurs\\:\\ 0\\.010376481439542288\ \(0\)\
\-\ pelvic\\:\\ 0\\.010376481439542288\ \(0\)\
\-\ 12\\:\\ 0\\.010347332633497875\ \(0\)\
\-\ are\\:\\ 0\\.010339117211801198\ \(0\)\
\-\ shown\\:\\ 0\\.010137416254881649\ \(0\)\
\-\ sagittal\\:\\ 0\\.01008386583581769\ \(0\)\
\-\ enlargement\\:\\ 0\\.010031267474807974\ \(0\)\
\-\ also\\:\\ 0\\.009968163276154742\ \(0\)\
\-\ worsening\\:\\ 0\\.009954082752665083\ \(0\)\
\-\ cysts\\:\\ 0\\.009903722730270315\ \(0\)\
\-\ images\\:\\ 0\\.009699786342895585\ \(0\)\
\-\ referred\\:\\ 0\\.009540033856377637\ \(0\)\
\-\ confirmed\\:\\ 0\\.00950709941741656\ \(0\)\
\-\ pelvis\\:\\ 0\\.009186660966247422\ \(0\)\
\-\ presence\\:\\ 0\\.009176880527979672\ \(0\)\
\-\ n\\/a\\:\\ 0\\.009157416116447001\ \(0\)\
\-\ intensity\\:\\ 0\\.009138078924199116\ \(0\)\
\-\ care\\:\\ 0\\.009118867299019978\ \(0\)\
\-\ by\\:\\ 0\\.008419354457070264\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.008414960308213123\ \(0\)\
\-\ be\\:\\ 0\\.007797377061206681\ \(0\)\
\-\ diffuse\\:\\ 0\\.007653868107619275\ \(0\)\
\-\ decreased\\:\\ 0\\.007517030777291596\ \(0\)\
\-\ primary\\:\\ 0\\.007489302552945847\ \(0\)\
\-\ in\\:\\ 0\\.0074804242036731645\ \(0\)\
\-\ demonstrated\\:\\ 0\\.007418402314961442\ \(0\)\
\-\ wall\\:\\ 0\\.00732295597703771\ \(0\)\
\-\ level\\:\\ 0\\.0072866539279495025\ \(0\)\
\-\ axial\\:\\ 0\\.007215359396650507\ \(0\)\
\-\ region\\:\\ 0\\.007140832033252404\ \(0\)\
\-\ include\\:\\ 0\\.007092170082929842\ \(0\)\
\-\ a\\:\\ 0\\.0070402331683775375\ \(0\)\
\-\ however\\:\\ 0\\.007039550460346362\ \(0\)\
\-\ low\\:\\ 0\\.007030082996646152\ \(0\)\
\-\ lesions\\:\\ 0\\.006767930492141857\ \(0\)\
\-\ patients\\:\\ 0\\.006543120116467532\ \(0\)\
\-\ symptoms\\:\\ 0\\.006300761765970826\ \(0\)\
\-\ and\\:\\ 0\\.005858281251640245\ \(0\)\
\-\ small\\:\\ 0\\.0058241872318968\ \(0\)\
\-\ demonstrate\\:\\ 0\\.005817905743588878\ \(0\)\
\-\ were\\:\\ 0\\.005740492120384382\ \(0\)\
\-\ well\\:\\ 0\\.005719174417067015\ \(0\)\
\-\ demonstrates\\:\\ 0\\.005522547933885165\ \(0\)\
\-\ findings\\:\\ 0\\.005381174366242484\ \(0\)\
\-\ female\\:\\ 0\\.005197515595999507\ \(0\)\
\-\ patient\\:\\ 0\\.0050685913071975616\ \(0\)\
\-\ the\\:\\ 0\\.004908258628531094\ \(0\)\
\-\ of\\:\\ 0\\.004825601216484728\ \(0\)\
\-\ within\\:\\ 0\\.004822873989307933\ \(0\)\
\-\ which\\:\\ 0\\.0047193626841495525\ \(0\)\
\-\ on\\:\\ 0\\.004283378771393066\ \(0\)\
\-\ at\\:\\ 0\\.0034253347716912217\ \(0\)\
\-\ or\\:\\ 0\\.0029630850561056434\ \(0\)\
\-\ was\\:\\ 0\\.00292389799471505\ \(0\)\
\-\ this\\:\\ 0\\.002843601222822879\ \(0\)\
\-\ year\\:\\ 0\\.0028287138144169072\ \(0\)\
\-\ with\\:\\ 0\\.0027693296115950234\ \(0\)\
\-\ old\\:\\ 0\\.0025885638960421735\ \(0\)\
\-\ \\.\\:\\ 0\\.0022055924794209224\ \(0\)\
\-\ \\(\\:\\ 0\\.002137164870543966\ \(0\)\
\-\ \\)\\:\\ 0\\.002111058260690252\ \(0\)\
\-\ to\\:\\ 0\\.0012635151137366457\ \(0\)\
